Upon completion of this activity, participants should be able to:

• Describe the evidence behind current practices related to liver transplantation for patients with alcohol use disorder and alcohol-associated liver         disease.
• Review post-transplant outcomes in patients with alcohol use disorder and alcohol-associated liver disease.
• Identify approaches to providing alcohol use disorder treatment for patients with alcohol-associated liver disease across the pre- and post-transplant continuum

This webinar is hosted by the American Association for the Study of Liver Diseases (AASLD). AASLD is a PCSS-MAUD partner.

Funding for this initiative was made possible by cooperative
agreement no. 1H79TI086771-01 from SAMHSA. The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily
reflect the official policies of the Department of Health and Human Services; nor does
mention of trade names, commercial practices, or organizations imply endorsement by
the U.S. Government.

The American Association for the Study of Liver Diseases is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association for the Study of Liver Diseases designates this blended (live and enduring) activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.